Modulation and compensation of the mRNA expression of energy related transporters in the brain of glucose transporter 1-deficient mice

Sumio Ohtsuki, Tazuru Kikkawa, Satoko Hori, Tetsuya Terasaki

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Facilitative glucose transporter 1 (GLUT1) is the molecule responsible for the entry of glucose into the brain, and its mutation is known as GLUT1 deficiency syndrome (GLUT1DS) in humans. To clarify the effect of GLUT1 gene deficiency, we have produced GLUT1-deficient mice, and investigated the developmental expression of GLUT1, monocarboxylate transporter 1 (MCT1) and MCT2 in the brains of these mice. Since the homozygotes were found to be embryonically lethal and the heterozygotes exhibited no abnormalities, GLUT1deficiency was examined using heterozygote mice. GLUT1 deficiency did not significantly affect the mRNA levels of GLUT1 at P0, P7 and in adults, or the levels of MCTs at P7, P14 and in adults. The GLUT1 level at P14 was reduced by 46.9%, although this was not statistically significant. The MCTs levels at P0 were increased about 2.0-fold in the deficient mice compared with the wild type. Furthermore, at P0, GLUT1 mRNA levels in wild type females were 1.91-fold higher than in wild type males. These results suggest that GLUT1 deficiency affects GLUT1 mRNA expression in the infant brain, and that of MCT1 and MCT2 in the neonatal brain. Furthermore, a compensatory effect of GLUT1 expression was observed in the brain of adult deficient mice. These effects of GLUT1 deficiency in the brain provide a molecular basis to assist in our understanding of the symptoms of GLUT1DS.

Original languageEnglish
Pages (from-to)1587-1591
Number of pages5
JournalBiological and Pharmaceutical Bulletin
Volume29
Issue number8
DOIs
Publication statusPublished - 2006 Aug 9
Externally publishedYes

Fingerprint

Facilitative Glucose Transport Proteins
Messenger RNA
Brain
Heterozygote
Homozygote

Keywords

  • Deficient syndrome
  • Gene compensation
  • Glucose transporter 1 (GLUT1)
  • Monocarboxylate transporter
  • mRNA expression
  • OmniBank

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Modulation and compensation of the mRNA expression of energy related transporters in the brain of glucose transporter 1-deficient mice. / Ohtsuki, Sumio; Kikkawa, Tazuru; Hori, Satoko; Terasaki, Tetsuya.

In: Biological and Pharmaceutical Bulletin, Vol. 29, No. 8, 09.08.2006, p. 1587-1591.

Research output: Contribution to journalArticle

@article{8949ded3885e4b23ab1acabbbab47ac4,
title = "Modulation and compensation of the mRNA expression of energy related transporters in the brain of glucose transporter 1-deficient mice",
abstract = "Facilitative glucose transporter 1 (GLUT1) is the molecule responsible for the entry of glucose into the brain, and its mutation is known as GLUT1 deficiency syndrome (GLUT1DS) in humans. To clarify the effect of GLUT1 gene deficiency, we have produced GLUT1-deficient mice, and investigated the developmental expression of GLUT1, monocarboxylate transporter 1 (MCT1) and MCT2 in the brains of these mice. Since the homozygotes were found to be embryonically lethal and the heterozygotes exhibited no abnormalities, GLUT1deficiency was examined using heterozygote mice. GLUT1 deficiency did not significantly affect the mRNA levels of GLUT1 at P0, P7 and in adults, or the levels of MCTs at P7, P14 and in adults. The GLUT1 level at P14 was reduced by 46.9{\%}, although this was not statistically significant. The MCTs levels at P0 were increased about 2.0-fold in the deficient mice compared with the wild type. Furthermore, at P0, GLUT1 mRNA levels in wild type females were 1.91-fold higher than in wild type males. These results suggest that GLUT1 deficiency affects GLUT1 mRNA expression in the infant brain, and that of MCT1 and MCT2 in the neonatal brain. Furthermore, a compensatory effect of GLUT1 expression was observed in the brain of adult deficient mice. These effects of GLUT1 deficiency in the brain provide a molecular basis to assist in our understanding of the symptoms of GLUT1DS.",
keywords = "Deficient syndrome, Gene compensation, Glucose transporter 1 (GLUT1), Monocarboxylate transporter, mRNA expression, OmniBank",
author = "Sumio Ohtsuki and Tazuru Kikkawa and Satoko Hori and Tetsuya Terasaki",
year = "2006",
month = "8",
day = "9",
doi = "10.1248/bpb.29.1587",
language = "English",
volume = "29",
pages = "1587--1591",
journal = "Biological and Pharmaceutical Bulletin",
issn = "0918-6158",
publisher = "Pharmaceutical Society of Japan",
number = "8",

}

TY - JOUR

T1 - Modulation and compensation of the mRNA expression of energy related transporters in the brain of glucose transporter 1-deficient mice

AU - Ohtsuki, Sumio

AU - Kikkawa, Tazuru

AU - Hori, Satoko

AU - Terasaki, Tetsuya

PY - 2006/8/9

Y1 - 2006/8/9

N2 - Facilitative glucose transporter 1 (GLUT1) is the molecule responsible for the entry of glucose into the brain, and its mutation is known as GLUT1 deficiency syndrome (GLUT1DS) in humans. To clarify the effect of GLUT1 gene deficiency, we have produced GLUT1-deficient mice, and investigated the developmental expression of GLUT1, monocarboxylate transporter 1 (MCT1) and MCT2 in the brains of these mice. Since the homozygotes were found to be embryonically lethal and the heterozygotes exhibited no abnormalities, GLUT1deficiency was examined using heterozygote mice. GLUT1 deficiency did not significantly affect the mRNA levels of GLUT1 at P0, P7 and in adults, or the levels of MCTs at P7, P14 and in adults. The GLUT1 level at P14 was reduced by 46.9%, although this was not statistically significant. The MCTs levels at P0 were increased about 2.0-fold in the deficient mice compared with the wild type. Furthermore, at P0, GLUT1 mRNA levels in wild type females were 1.91-fold higher than in wild type males. These results suggest that GLUT1 deficiency affects GLUT1 mRNA expression in the infant brain, and that of MCT1 and MCT2 in the neonatal brain. Furthermore, a compensatory effect of GLUT1 expression was observed in the brain of adult deficient mice. These effects of GLUT1 deficiency in the brain provide a molecular basis to assist in our understanding of the symptoms of GLUT1DS.

AB - Facilitative glucose transporter 1 (GLUT1) is the molecule responsible for the entry of glucose into the brain, and its mutation is known as GLUT1 deficiency syndrome (GLUT1DS) in humans. To clarify the effect of GLUT1 gene deficiency, we have produced GLUT1-deficient mice, and investigated the developmental expression of GLUT1, monocarboxylate transporter 1 (MCT1) and MCT2 in the brains of these mice. Since the homozygotes were found to be embryonically lethal and the heterozygotes exhibited no abnormalities, GLUT1deficiency was examined using heterozygote mice. GLUT1 deficiency did not significantly affect the mRNA levels of GLUT1 at P0, P7 and in adults, or the levels of MCTs at P7, P14 and in adults. The GLUT1 level at P14 was reduced by 46.9%, although this was not statistically significant. The MCTs levels at P0 were increased about 2.0-fold in the deficient mice compared with the wild type. Furthermore, at P0, GLUT1 mRNA levels in wild type females were 1.91-fold higher than in wild type males. These results suggest that GLUT1 deficiency affects GLUT1 mRNA expression in the infant brain, and that of MCT1 and MCT2 in the neonatal brain. Furthermore, a compensatory effect of GLUT1 expression was observed in the brain of adult deficient mice. These effects of GLUT1 deficiency in the brain provide a molecular basis to assist in our understanding of the symptoms of GLUT1DS.

KW - Deficient syndrome

KW - Gene compensation

KW - Glucose transporter 1 (GLUT1)

KW - Monocarboxylate transporter

KW - mRNA expression

KW - OmniBank

UR - http://www.scopus.com/inward/record.url?scp=33746715057&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33746715057&partnerID=8YFLogxK

U2 - 10.1248/bpb.29.1587

DO - 10.1248/bpb.29.1587

M3 - Article

C2 - 16880609

AN - SCOPUS:33746715057

VL - 29

SP - 1587

EP - 1591

JO - Biological and Pharmaceutical Bulletin

JF - Biological and Pharmaceutical Bulletin

SN - 0918-6158

IS - 8

ER -